Bank of New York Mellon »

X4 Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $917k 196k 4.67

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding X4 Pharmaceuticals

Morgan Stanley
FMR
Bain Capital Life Sciences Investors
Perceptive Advisors
Saturn V Capital Management
Empery Asset Management
Deep Track Capital
BlackRock
Kalehua Capital Management
Vanguard Capital Management
Rosalind Advisors
Braidwell
Blackstone Group
Trails Edge Capital Partners
Nantahala Capital Management

View all funds holding X4 Pharmaceuticals